Conference DVDs

2013 DVD CoverCONFERENCE SERIES: Technologies and Tools for Life Sciences

qPCR in Molecular Diagnostics 

Quantitative real-time PCR is a valuable technology used for diagnostics of diseases such as cancer and infectious diseases, and for the detection of bacterial, fungal and viral pathogens. This course covers aspects of incorporating qPCR into standard molecular diagnosis including the challenges involved, an overview of the technology available, and next steps.
Click here for more information    



Latest Advances in Molecular Pathology DVD CoverLatest Advances in Molecular Pathology
This course is designed to educate practicing pathologists on the current molecular diagnostics technologies. This three part course is produced in collaboration between Cambridge Healthtech Institute and the College of American Pathologists.
Click here for more information    




2012 Dx DVD CoverDiagnostics Channel - Moving Diagnostics to the Clinic 
This DVD showcases the best of the Diagnostics Channel at the 2012 Molecular Medicine Tri-Con. Coverage includes improving patient outcomes by adoption of genomic analysis, FDA perspectives on regulation of LDTs and companion diagnostics, next-generation sequencing for the clinic, and the prognostic and predictive value of enumeration and molecular characterization of circulating tumor cells. An overview of genomic screening and carrier detection are also addressed.
Click here for more information    




2012 SC11 DVD CoverCTCs from Bench to Bed 
This course will focus on validation of CTC research data for clinical practice, correlations between CTCs, diagnosis and responses to therapy.
Click here for more information    




2012 SC3 DVD CoverUnderstanding EMT: Mechanisms and Metastasis to MET 
Epethelial Mesenchymal Transition (EMT) plays a critical role in cancer cells, but understanding of its mechanisms is incomplete. EMT causes cells to develop increased motility, invasiveness, and greater resistance to apoptosis. These changes make the cells more like stem cells, allowing them to self renew.
Click here for more information    




2011 SC2 DVD CoverRoadmap for Accelerating Commercialization of Molecular Diagnostics 
This short course is focused on development of molecular diagnostics as they make their way from biomarker discovery and initial proof of clinical performance through to commercial launch, partnership delivery, and market development.  The course will emphasize identification of critical hurdles that when addressed properly, can materially accelerate progress.  
Click here for more information    




2011 SC3 DVD CoverBest Practices in Translational & Personalized Medicine  
Award-winner speakers from the 2010 Bio-IT World Best Practices competition—including the winners of the 2010 Judges’ Prize and the 2010 Best Practice in Personalized & Translational Medicine—will give attendees an in-depth look at cutting edge solutions and techniques for advancing translational medicine research.
Click here for more information    




2011 SC4 DVD CoverIdentification, Characterization and Targeting of Cancer Stem Cells 
This short course reports on the considerable progress of identifying and validating specific targets on stem cells that are not present on other cells, and on specific therapeutics for these targets and for stem cell specific pathways that inhibit tumour growth and reduce CSC frequency. Moreover it covers new studies that focus on gene expression signatures revealing new therapeutic targets that are providing promising results in prostate cancers. 
Click here for more information    




2011 SC6 DVD CoverApplying Next-Generation Sequencing Technologies: Introduction to New Technologies and Application in Research 
Technologies for next generation sequencing are accelerating at a rapid pace. This DVD will present up-to-date information on the newest options for DNA sequencing, and the tools to manage the data.
Click here for more information    




2011 SC8 DVD CoverSmarter Studies: Designing Efficient and Rigorous Molecular Diagnostics and Biomarker Studies 
Omics measurements are inherently comparative—we compare healthy to diseased, responders to non-responders, good vs. poor prognosis, etc.  The focus of these evaluations is on the how of the comparison (the technology), but it matters just as much what we compare (samples, conditions).  It is generally difficult and costly to improve the measurement performance, but it is often rather simple to achieve a quantum leap in the quality and validity of your results with an improved study design. 
Click here for more information    




2011 SC9 DVDBuilding an Ontological Framework from Drug Discovery to Clinical Data
Ontologies are increasingly used to formally specify objects and their relations in biological and medical domains and to drive modeling, integration, and analysis of data from genomics, proteomics, drug research, disease, treatment, and electronic health records.
Click here for more information    



Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors

Beckman Coulter Life Sciences 

Boston Healthcare



Charles River no tagline


Cofactor Genonics


Menarini Silicon Biosystems






View All Sponsors